Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Clinical trial NCT01900444 · COMPLETED

Trial details

NCT number: NCT01900444
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2013-07-11
Primary completion: 2014-03-11
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.